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Introduction: It is generally believed that people affected by papilledema will not have progressive damage to
their eyesight if they receive adequate medical care to treat the underlying cause of the papilledema. We present a
case that appears to contradict this widely accepted belief.
Case presentation: A 53-year-old Japanese man with tinnitus visited our hospital. His initial best-corrected visual
acuity in either eye was not impaired, although they both exhibited papilledema. Magnetic resonance imaging did
not reveal a mass or hemorrhagic lesion in our patient’s brain. Nevertheless, his best-corrected visual acuity
gradually deteriorated over the following three months. Angiography demonstrated a dural arteriovenous fistula in
his sigmoid sinus. After embolization therapy, the papilledema improved in both eyes. However, over the
subsequent four years, his best-corrected visual acuity progressively deteriorated due to an unknown cause, despite
the successful embolization of the dural arteriovenous fistula.
Conclusion: There may be delayed onset of an unknown pathophysiology in the visual system after treatment for
the underlying cause of papilledema, implying an uncertain visual prognosis for patients with this condition.
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Papilledema, also known as choked disc, is an edema of
the optic nerve head that is caused by elevated intracra-
nial pressure [1,2]. This condition is usually bilateral and
results from a cerebral tumor, cerebral abscess, meningi-
tis, encephalitis, subarachnoid hemorrhage, head injury,
hydrocephalus, or many other local or systemic patho-
logical conditions. In the early stages, the patient may
have a headache, but visual acuity may not be affected.
In advanced stages, the papilledema may progress to an
enlargement of the blind spot in visual field measure-
ments, blurred vision, visual obscurations, or even total
loss of vision. The timeline of visual impairment associ-
ated with papilledema is highly variable; major deficits* Correspondence: zako@aichi-med-u.ac.jp
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ally they arise over several months [3]. The risk of im-
paired visual acuity increases as the duration of the
edema increases [4], although the critical duration has
not been determined. However, a person affected by
papilledema is generally not expected to have progressive
damage to their eyesight if they receive adequate medical
care for the underlying cause of the papilledema.
We present the case report of a patient with bilateral
papilledema, which was caused by a dural arteriovenous
fistula (DAVF) in his sigmoid sinus. DAVFs are abnormal
arteriovenous connections within the dura mater that
involve a dural sinus and/or cortical veins. The most
common location for DAVFs is the transverse or sigmoid
sinus [5].
After administering the appropriate transarterial and
transvenous embolization therapy, our patient’s bilateral
papilledema improved considerably. However, his visuald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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disc paling, although he did not exhibit thinning of the
retina. Our experience with this patient suggests that there
may be delayed onset of an unknown pathophysiology in
the visual system after treatment for the underlying cause
of papilledema, implying an uncertain prognosis for
patients with this condition.
Case presentation
A 53-year-old Japanese man presented to our hospital
complaining of tinnitus over a period of three weeks. He
also noted slightly abnormal “fuzzy” vision in the previ-
ous two weeks. An otorhinologist was consulted to rule
out Vogt–Koyanagi–Harada disease.
An ocular evaluation revealed a best-corrected visual
acuity (BCVA) of 1.2 in his right eye and 1.0 in his left
eye. His intraocular pressure was 14mmHg in his right
eye and 16mmHg in his left eye. The anterior segment
was normal in both eyes. However, a fundus evaluation
revealed a significant papilledema in each eye (Figure 1).
Brain magnetic resonance imaging (MRI) demonstrated
the absence of an intracranial mass or hemorrhagic lesion.
Our patient did not experience hypertension or uveitis; at
that point, he had experienced no loss of BCVA. We did










Figure 1 Photographs showing optic discs before and after treatmen
transarterial and transvenous embolization therapy. (c) Optic disc four yeardid not approve the procedure. Because he did not
demand further examination, we held follow-up appoint-
ments with our patient every two weeks.
Our patient had been taking aripiprazole for depres-
sion for over seven years. He was also diagnosed with
mild cognitive impairment, also known as incipient de-
mentia, for which he was not receiving treatment.
Ten weeks after his first visit to our hospital, our pa-
tient began to experience sporadic marked blurred vision
and transient day blindness. His BCVA had deteriorated
moderately to 0.9 in his right eye and 0.8 in his left eye.
A neurosurgeon detected a DAVF in his sigmoid sinus
on angiography. The fistula was classified as type I, ac-
cording to Borden classification, and type IIa, according
to Cognard classification.
Transarterial and transvenous embolization was suc-
cessfully performed to treat the causative DAVF. Three
weeks after therapy, the papilledema had significantly
improved (Figure 1) but the BCVA in our patient’s right
and left eyes was 0.8 and 0.3, respectively. His tinnitus
disappeared by one week after embolization therapy.
The angiography results before and after embolization
are presented in Figure 2.
We followed this patient for four years. Regular ocular
examinations demonstrated the absence of papilledemaLeft
t. (a) Optic disc on the first visit. (b) Optic disc three months after





Figure 2 Angiography before and after embolization therapy.
Right external carotid angiography (lateral view) demonstrates blood
flow into the sigmoid sinus venosus (arrowheads) through the dural
arteriovenous fistula. Paired photographs show images of the same
phases after embolization therapy. Arrows indicate the time course,
from top (early) to bottom (late).
Figure 3 Best-corrected visual acuity and critical fusion
frequency of the patient. BCVA, best-corrected visual acuity;










Figure 4 Images of macula and retina around the disc,
analyzed by optical coherence tomography over the last
three years.
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deteriorate progressively (Figure 3), with concurrent
complete disc paling (Figure 1) but without thinning of
the foveal retina or retina around the disc, as determined
by optical coherence tomography (OCT) (Figure 4).
A mild vitreomacular adhesion in his right eye was re-
vealed by OCT with SDOCT RS-3000 (Nidek Co., Ltd,
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System EX version 1.3.0.3 (Nidek Co., Ltd) (Figure 4).
Our patient did not notice metamorphopsia, and he did
not request pars plana vitrectomy. Goldmann perimetry
showed progressive narrowing of the visual field in both
eyes after embolization (Figure 5).
Four years after embolization, our patient’s BCVA was
0.15 in his right eye and 0.04 in his left eye. His intraoc-
ular pressure was within normal range in both eyes at all
examinations (data not shown). Our patient’s intracra-
nial condition was examined by MRI and magnetic res-
onance angiogram every six months, but he never had a
recurrence of the right DAVF in the sigmoid sinus, nor
were there any other abnormal findings.
Discussion
Patients with papilledema are generally not expected to
have progressive damage to their eyesight if they receive
adequate medical care to treat the underlying cause of
the papilledema. However, the prognosis for visual func-
tion can not be determined simply by measuring the ex-
tent of damage before treatment. As shown in this case,
visual function can continue to deteriorate despite an
initial improvement after effective surgery.Figure 5 Goldmann kinetic visual field, obtained before and after tranTo the best of our knowledge, our case report is the
first in the literature to describe the progressive deterior-
ation of visual function after appropriate treatment in a
patient with DAVF. We speculate that there may have
been delayed onset of an unknown pathophysiology in
his visual system after treatment for the underlying
cause of papilledema, implying an uncertain prognosis
with respect to the disease.
It is unclear what caused the initially improved visual
function to deteriorate in the few years following treat-
ment. Papilledema can have a number of effects on the
visual system, the most severe of which is nerve fiber
dysfunction from swelling, with subsequent and progres-
sive loss of the retinal nerve fibers and optic atrophy [6].
Although the definitive pathogenesis of papilledema in
response to increased intracranial pressure remains un-
clear, the prevailing theory is that papilledema is primarily
a mechanical nonvascular phenomenon [7,8]. According
to this theory, optic disc swelling causes axon compres-
sion, which results in hypoxia, ischemia, gliosis, and, fi-
nally, optic atrophy due to delayed death or degeneration
of neuronal or retinal cells [6,9]. Another possibility for
the mechanism underlying the delayed neurodegeneration
is apoptosis. Optic nerve lamina cribrosa cells that aresarterial and transvenous embolization therapy.
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and neurogenesis [10].
A technique was developed in monkeys to produce
papilledema by inflating intracranial balloons [11]. With
this method, papilledema did not develop in optic nerves
subjected to procedures that resulted in total optic atro-
phy prior to the elevation of intracranial pressure [12].
Thus, in following up the cause for papilledema in a
patient with total optic atrophy, we should use not only
fundoscopy but also other appropriate examinations
such as intracranial pressure measurement, MRI, and
magnetic resonance angiography (MRA).
No remarkable progressive abnormal retinal atrophy
was detected by OCT in our case. A central scotoma
was detected just after embolization in our patient’s left
eye, and another scotoma was detected 2.5 years after
therapy in his right eye, suggesting the involvement of
optic neuropathy. However, his visual field did not in-
dicate a more specific disease or lesion. The precise
mechanism of the delayed-onset optic atrophy remains
unclear.
A dural arteriovenous malformation is difficult to
recognize with brain computed tomography (CT) or
MRI, but it can be well documented by MRA and cere-
bral angiography [13]. In this case, we spent almost three
months obtaining an accurate diagnosis, as initial cranial
CT and MRI images did not show any abnormal find-
ings. The DAVF was a cause of the papilledema in this
case. The pathogenic theory of papilledema is that it is
caused by an increase in cerebral blood volume due to
impaired cranial venous outflow, leading to intracranial
hypertension [14]. Therefore, if a patient has bilateral
papilledema, clinicians should perform MRA or cerebral
angiography to rule out intracranial circulatory malfor-
mations [15].
If a patient has papilledema plus depression and/or de-
mentia, DAVF should be considered as a cause of these
disorders. However, the relationships among DAVF, de-
teriorated visual function, and symptoms of depression
and dementia are not straightforward. DAVF is a cause
of depression [16-18], and depression may improve after
the DAVF is treated [16]. DAVF is also implicated as a
cause of dementia, and dementia may be reversed after
treatment for the DAVF [19-25]. Deteriorated visual
function itself may elicit depressive symptoms in pa-
tients [26-28]. A possible explanation for the lack of
significant improvement in our patient’s symptoms of
depression may be that his visual function continued to
deteriorate.
Conclusion
We have described our experience with a case of bilat-
eral papilledema, which was induced by a DAVF in the
sigmoid sinus and subsequently improved followingembolization therapy. However, our patient’s visual func-
tion progressively deteriorated after the successful ther-
apy. This delayed onset of unknown pathophysiology in
the visual system after treatment for the underlying
cause of papilledema implies an uncertain prognosis for
the disease.
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